Product Information
METFORMIN ER 1,000 MG OSM-TAB is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.3142 per EA under NDC 27241018960. Its NADAC has been published 295 times since Feb 10, 2021.
FDA first approved this application on Apr 9, 2020. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1000 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241018960
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213651FDA Approved
4/9/2020
TE Code
AB2
On Market Since
4/9/2020
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN ER 1,000 MG OSM-TAB has been published 295 times since Feb 10, 2021, and over the history we have for it it has declined 88.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3142 per EA |
|---|---|
| All-time high | $2.8180 (Mar 10, 2021) |
| All-time low | $0.2243 (Feb 18, 2026) |
| 52-week high | $0.3262 |
| 52-week low | $0.2243 |
| Median price | $0.4723 |
| Average price | $0.7746 |
| Largest weekly change | +65.9% (Feb 23, 2022) |
| Weeks tracked | 295 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metformin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Biguanide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METFORMIN ER 1,000 MG OSM-TAB?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN ER 1,000 MG OSM-TAB, manufactured by Ajanta Pharma USA Inc., is $0.3142 per EA (NDC 27241018960), effective Sep 30, 2026.
How has the price of METFORMIN ER 1,000 MG OSM-TAB changed over time?
Over the history we have for it, the NADAC for METFORMIN ER 1,000 MG OSM-TAB has declined 88.4%. It has been tracked across 295 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for METFORMIN ER 1,000 MG OSM-TAB?
Since Feb 10, 2021, the NADAC for METFORMIN ER 1,000 MG OSM-TAB has ranged from a low of $0.2243 (Feb 18, 2026) to a high of $2.8180 (Mar 10, 2021), with a median of $0.4723 per EA.
Are there cheaper alternatives to METFORMIN ER 1,000 MG OSM-TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL 1,000 MG TABLET, is $0.0232 per EA — about 93% below METFORMIN ER 1,000 MG OSM-TAB.
Who manufactures METFORMIN ER 1,000 MG OSM-TAB?
METFORMIN ER 1,000 MG OSM-TAB (NDC 27241018960) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.